Increased Level of Phosphorylated ShcA Measured by Chemiluminescence-Linked Immunoassay Is a Predictor of Good Prognosis in Primary Breast Cancer Expressing Low Levels of Estrogen Receptor
The SH2 domain-containing adaptor protein ShcA is a proto-oncogene involved in growth factor receptor signaling. The role of phosphorylated ShcA is to link receptor tyrosine kinases with the SH2-containing adaptor protein Grb2, thus facilitating signal transduction from receptor tyrosine kinases to...
Main Authors: | Serenella Eppenberger-Castori, Urs Eppenberger, Willy Küng, Jonas Cicenas |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2010-03-01
|
Series: | Cancers |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6694/2/1/153/ |
Similar Items
-
Ras, TrkB, and ShcA Protein Expression Patterns in Pediatric Brain Tumors
by: Monika Prill, et al.
Published: (2021-05-01) -
p66ShcA functions as a contextual promoter of breast cancer metastasis
by: Kyle Lewis, et al.
Published: (2020-01-01) -
Genetic inactivation of mitochondria-targeted redox enzyme p66ShcA preserves neuronal viability and mitochondrial integrity in response to oxidative challenges
by: Michael eForte, et al.
Published: (2012-07-01) -
p66ShcA promotes malignant breast cancer phenotypes by alleviating energetic and oxidative stress
by: Kyle Lewis, et al.
Published: (2024-04-01) -
Mitochondrial dysfunction and neurodegeneration in multiple sclerosis
by: Kimmy eSu, et al.
Published: (2013-07-01)